Vol. 3 No. 3-S2 (2009): CUAJ June-Suppl 2

View Vol. 3 No. 3-S2 (2009): CUAJ June-Suppl 2

Published: 2013-05-01

Supplement-Introduction

Sharing the responsibility of prostate cancer risk reduction

Laurence Klotz, Yves Fradet, Larry Goldenberg, Simon Tanguay

S91
- PDF

Review

Diagnosis and management of benign prostatic hyperplasia in primary care

Simon Tanguay, Murray Awde, Gerald Brock, Richard Casey, Joseph Kozak, Jay Lee, J. Curtis Nickel, Fred Saad

S92-S100
- PDF
The burden of prostate cancer in Canada

Yves Fradet, Laurence Klotz, John Trachtenberg, Alexandre Zlotta

S102-S108
- PDF
The role of 5-alpha reductase inhibitors in prostate pathophysiology: Is there an additional advantage to inhibition of type 1 isoenzyme?

Larry Goldenberg, Alan So, Neil Fleshner, Ricardo Rendon, Darrel Drachenberg, Mostafa Elhilali

S109-S114
- PDF
Gleason grading controversies: what the chemoprevention trials have taught us

Laurence Klotz, Darrel Drachenberg, Yves Fradet, Fred Saad, John Trachtenberg, Alexandre Zlotta

S115-S120
- PDF